The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies

Macular Degeneration Clinical Trial

Official title: The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies

Status Completed

Clinical Trial Summary

Patients who develop macular diseases have several clinical complications,such as central vision loss, the central scotoma of the visual field, the decrease of reading speed and fixation stability. At present, there is still no satisfactory effect in the prevention and treatment of advanced macular disease. A new rehabitation strategy named microperimetric biofeedback training has been shown to be effective in improving patients' visual appearance, but there is no consensus regarding the optimal methodology and standard of practice. Therefore, we designed a prospective clinical study to verify the effectiveness of MBFT and to determine an optimal plan.

Clinical Trial Description

The present study aimed to investigate the effects of training frequency and number of training sessions on the visual outcomes of patients with various macular diseases. A total of 15 training sessions were conducted on two distinct frequencies, namely once a day and once every other day. Baseline measurements included fixation stability, reading speed, and best corrected visual acuity (BCVA) were obtained and followed up after the 5, 10, and 15 training sessions. By comparing the changes in these visual function parameters across different stages of training, the study aimed to identify and analyze the underlying patterns and rules governing the training process. Ultimately, the results of this study could serve as a valuable reference for standardizing the use of MBFT in clinical practice. ;

Related Conditions & MeSH terms

• Low Vision
• Macular Degeneration
• Stargardt Disease
• Vision, Low

• NCT number: NCT05904444
• Study type: Interventional
• Source: Aier Eye Hospital, Guangzhou
• Status: Completed
• Phase: N/A
• Start date: August 15, 2018
• Completion date: April 30, 2023